End-Stage Renal Disease: Symptoms, Risk Factors & Treatments

Introduction

End-stage renal disease (ESRD) is a serious condition in which the kidneys can no longer filter waste and excess fluids from the blood. It represents the final stage of chronic kidney disease (CKD) and requires either dialysis or a kidney transplant to sustain life. ESRD is a growing public health concern, affecting millions of people worldwide. This article aims to provide a clear and comprehensive overview of ESRD, covering its risk factors, symptoms, diagnostic tests, treatment options, and ways to manage symptoms at home. By the end of this guide, you will have a better understanding of ESRD, its progression, and how to manage your health effectively.

What is End-Stage Renal Disease?

End-stage renal disease (ESRD) occurs when the kidneys lose their ability to function, making dialysis or a kidney transplant necessary. This article will explore the risk factors, symptoms, diagnostic tests, treatments, and home management strategies for ESRD.

Description of End-Stage Renal Disease

End-stage renal disease (ESRD) occurs when the kidneys can no longer perform essential functions such as filtering waste and balancing fluids. It is the final stage of chronic kidney disease (CKD), which progresses over time as kidney function declines. In ESRD, kidney function drops to less than 15% of normal capacity, making it impossible to maintain a healthy balance of fluids, electrolytes, and waste without medical intervention.

ESRD typically follows years of chronic kidney disease, often caused by conditions like diabetes, high blood pressure, or glomerulonephritis (inflammation of the kidney’s filtering units). As kidney function deteriorates, symptoms such as fatigue, swelling, and difficulty concentrating may appear. Without treatment, ESRD can lead to life-threatening complications, including heart disease, bone disease, and fluid overload.

According to the National Kidney Foundation, approximately 750,000 people in the U.S. live with ESRD, with over 500,000 relying on dialysis. The global prevalence of ESRD continues to rise, largely due to increasing rates of diabetes and hypertension. Early detection and management of CKD can slow progression to ESRD, but once the disease reaches this stage, treatment options are limited to dialysis or kidney transplantation.

Risk Factors for Developing End-Stage Renal Disease

Lifestyle Risk Factors

Certain lifestyle choices significantly increase the risk of developing ESRD. A poor diet, particularly one high in sodium, processed foods, and unhealthy fats, is a common risk factor. These dietary habits can lead to high blood pressure and diabetes, the leading causes of ESRD. Smoking is another major risk factor, as it damages blood vessels and reduces blood flow to the kidneys, accelerating kidney damage.

Lack of physical activity also contributes to ESRD risk. Regular exercise helps maintain healthy blood pressure and blood sugar levels, both crucial for kidney health. Obesity, often linked to poor diet and lack of exercise, is another significant risk factor, as it increases the likelihood of developing diabetes and hypertension.

Medical Risk Factors

Several medical conditions increase the risk of developing ESRD. Diabetes, particularly type 2, accounts for nearly half of all ESRD cases. High blood sugar over time damages the blood vessels in the kidneys, reducing kidney function.

Hypertension, or high blood pressure, is another major risk factor. Consistently high blood pressure strains the kidneys, damaging the small blood vessels that filter waste. Other conditions that increase ESRD risk include glomerulonephritis, polycystic kidney disease (a genetic disorder causing cysts in the kidneys), and recurrent urinary tract infections (UTIs).

Genetic and Age-Related Risk Factors

Genetics also play a role in ESRD development. A family history of kidney disease increases your risk. Certain genetic disorders, like polycystic kidney disease, can directly lead to ESRD. Additionally, people of African American, Hispanic, Native American, or Asian descent are at higher risk, possibly due to a combination of genetic and socioeconomic factors.

Age is another important risk factor. As people age, kidney function naturally declines. Individuals over 60 are more likely to develop ESRD, especially if they have other risk factors like diabetes or hypertension. Early detection and management of kidney disease in older adults are crucial to slowing progression to ESRD.

Clinical Manifestations of End-Stage Renal Disease

Fatigue

Fatigue is one of the most common symptoms of ESRD, affecting 70-80% of patients. This overwhelming tiredness can occur at any stage of kidney disease but becomes more pronounced as kidney function declines. The kidneys filter waste from the blood, and when they fail, toxins build up, causing fatigue. Anemia, common in ESRD, further contributes to exhaustion. Anemia occurs because the kidneys produce less erythropoietin, a hormone that stimulates red blood cell production, leading to fewer oxygen-carrying cells in the bloodstream.

Nausea

Nausea affects 30-50% of ESRD patients, especially in the later stages. As kidney function deteriorates, waste products like urea accumulate in the blood, causing uremia. This buildup irritates the gastrointestinal tract, leading to nausea, often worse in the morning or after eating. Severe cases can result in appetite loss and weight loss, complicating ESRD management.

Vomiting

Vomiting affects 20-30% of ESRD patients, often accompanying nausea. It is caused by the buildup of uremic toxins in the bloodstream. The body attempts to rid itself of these toxins through vomiting, but this can lead to dehydration and electrolyte imbalances, worsening kidney function. Vomiting is more common in advanced ESRD and significantly impacts quality of life.

Swelling

Swelling, or edema, affects 60-70% of ESRD patients. The kidneys regulate fluid balance, and when they fail, excess fluid accumulates in tissues, causing swelling, particularly in the legs, ankles, and feet. Swelling can also occur in the face and hands. In severe cases, fluid may build up in the lungs, causing shortness of breath. Managing fluid intake and using diuretics can help reduce swelling, but it remains a challenging symptom for many patients.

Shortness of Breath

Shortness of breath, or dyspnea, affects 40-50% of ESRD patients. It can result from fluid overload, anemia, and heart failure, common ESRD complications. When the kidneys fail to remove excess fluid, it can accumulate in the lungs, making breathing difficult. Anemia also reduces the blood’s oxygen-carrying capacity, leading to shortness of breath, especially during physical activity.

Confusion

Confusion or cognitive impairment affects 20-30% of ESRD patients, particularly in later stages. The buildup of uremic toxins in the blood can impair brain function, leading to confusion, difficulty concentrating, and memory problems. This condition, known as uremic encephalopathy, can range from mild cognitive impairment to severe disorientation and even coma. Dialysis can help remove some toxins and improve mental clarity, but cognitive issues may persist in some patients.

Itching

Itching, or pruritus, affects 40-60% of ESRD patients. The cause is not fully understood but is thought to be related to toxin buildup, dry skin, and imbalances in calcium and phosphorus levels. Itching can be localized or widespread and is often worse at night, leading to sleep disturbances. Managing phosphorus levels and using moisturizers or medications can help alleviate itching, but it remains a persistent problem for many patients.

Decreased Urine Output

Decreased urine output is a hallmark of ESRD, affecting nearly all patients as the disease progresses. In early kidney disease, patients may produce normal amounts of urine, but as kidney function declines, urine output decreases. In the final stages of ESRD, some patients may stop producing urine altogether, a condition known as anuria.

High Blood Pressure

High blood pressure, or hypertension, affects 85-90% of ESRD patients. The kidneys regulate blood pressure by controlling sodium and water balance. When the kidneys fail, this balance is disrupted, leading to fluid retention and increased blood pressure. Damaged kidneys may also produce more renin, a hormone that raises blood pressure. Managing hypertension is crucial in ESRD, as uncontrolled high blood pressure can further damage the kidneys and increase the risk of heart disease.

Anemia

Anemia affects 70-80% of ESRD patients. The kidneys produce erythropoietin, a hormone that stimulates red blood cell production. When kidney function declines, erythropoietin production decreases, leading to fewer red blood cells and anemia. Anemia causes fatigue, weakness, and shortness of breath, significantly impacting quality of life. Treatment typically involves erythropoiesis-stimulating agents (ESAs) and iron supplements to boost red blood cell production.

Diagnostic Evaluation of End-Stage Renal Disease

Diagnosing end-stage renal disease (ESRD) involves clinical evaluation, laboratory tests, and imaging studies. Healthcare providers assess kidney function by measuring waste products in the blood, such as urea and creatinine, and calculating the glomerular filtration rate (GFR), which indicates how well the kidneys filter blood. Urine tests can detect protein or blood, signaling kidney damage. Imaging studies, like ultrasounds or CT scans, provide a visual assessment of kidney size and structure. In some cases, a kidney biopsy may be performed to examine kidney tissue under a microscope. Together, these tests confirm the diagnosis of ESRD and guide treatment decisions.

Blood Urea Nitrogen (BUN)

Test Information: The Blood Urea Nitrogen (BUN) test measures the amount of urea nitrogen in the blood. Urea is a waste product formed when the liver breaks down proteins, and it is normally filtered out by the kidneys and excreted in urine. The BUN test is a simple blood test where a small sample is drawn from a vein, usually in the arm. Elevated BUN levels indicate that the kidneys are not functioning properly and are unable to remove urea from the blood. This test is crucial in diagnosing ESRD as it helps assess how well the kidneys are filtering waste products.

Results that Indicate End-Stage Renal Disease: Normal BUN levels range from 7 to 20 mg/dL. In ESRD patients, BUN levels are often significantly elevated, sometimes exceeding 50 mg/dL. Elevated BUN levels suggest the kidneys are not effectively filtering waste. However, BUN levels can also be affected by dehydration, high protein intake, or liver disease, so healthcare providers interpret BUN results alongside other tests, like serum creatinine and GFR. If BUN levels are elevated but other tests are normal, further evaluation may be necessary to determine the cause.

Serum Creatinine

Test Information: Serum creatinine is another blood test that measures creatinine, a waste product from muscle metabolism. Like urea, creatinine is normally filtered out by the kidneys and excreted in urine. The serum creatinine test is performed by drawing a blood sample from a vein. Elevated creatinine levels indicate that the kidneys are not functioning properly. This test is crucial in diagnosing ESRD because creatinine levels are directly related to kidney function.

Results that Indicate End-Stage Renal Disease: Normal serum creatinine levels range from 0.6 to 1.2 mg/dL in men and 0.5 to 1.1 mg/dL in women. In ESRD patients, serum creatinine levels are often significantly elevated, sometimes exceeding 5 mg/dL. Elevated creatinine levels suggest the kidneys are not effectively filtering waste. Healthcare providers use serum creatinine levels to calculate the glomerular filtration rate (GFR), which provides a more accurate assessment of kidney function. If serum creatinine levels are elevated but other tests are normal, further evaluation may be needed.

Glomerular Filtration Rate (GFR)

Test Information: The Glomerular Filtration Rate (GFR) estimates how well the kidneys filter blood. GFR is calculated using a formula that considers serum creatinine levels, age, gender, and race. The GFR test does not require a separate blood draw; it is calculated based on serum creatinine results. GFR is one of the most important tests for diagnosing ESRD because it provides a direct measure of kidney function. A low GFR indicates the kidneys are not filtering blood effectively, a hallmark of ESRD.

Results that Indicate End-Stage Renal Disease: Normal GFR values range from 90 to 120 mL/min/1.73 m². In ESRD patients, GFR is usually less than 15 mL/min/1.73 m², indicating severe kidney damage. A GFR below 60 mL/min/1.73 m² for three months or more is considered chronic kidney disease (CKD), and a GFR below 15 mL/min/1.73 m² is classified as ESRD. If GFR is low but other tests are normal, healthcare providers may repeat the test or perform additional evaluations to confirm the diagnosis.

Urinalysis

Test Information: Urinalysis examines the appearance, concentration, and content of urine. It is performed by collecting a urine sample, which is then analyzed in a lab. Urinalysis can detect abnormalities like protein, blood, or glucose in the urine, which may indicate kidney damage. This test is important in diagnosing ESRD because it can reveal early signs of kidney dysfunction, such as proteinuria (excess protein in the urine) or hematuria (blood in the urine).

Results that Indicate End-Stage Renal Disease: In ESRD patients, urinalysis may show elevated levels of protein (proteinuria) or blood (hematuria) in the urine. Proteinuria is a common sign of kidney damage, as the kidneys normally prevent large molecules like protein from passing into the urine. Hematuria may indicate damage to the kidney’s filtering units, known as glomeruli. If urinalysis results are abnormal, healthcare providers may perform additional tests, such as a kidney biopsy, to confirm the diagnosis of ESRD.

Kidney Ultrasound

Test Information: A kidney ultrasound is a non-invasive imaging test that uses sound waves to create pictures of the kidneys. During the test, a technician applies a gel to the patient’s abdomen and moves a handheld device called a transducer over the skin. The transducer sends sound waves into the body, which bounce off the kidneys and create images on a monitor. This test is important in diagnosing ESRD because it can reveal structural abnormalities, such as kidney shrinkage or cysts, that may indicate kidney damage.

Results that Indicate End-Stage Renal Disease: In ESRD patients, a kidney ultrasound may show that the kidneys are smaller than normal, a condition known as kidney atrophy. This occurs because damaged kidney tissue is replaced by scar tissue, causing the kidneys to shrink. The ultrasound may also reveal cysts, tumors, or other structural abnormalities that could be contributing to kidney dysfunction. If the ultrasound results are normal but other tests indicate kidney damage, healthcare providers may perform additional imaging studies, such as a CT scan or MRI, to get a more detailed view of the kidneys.

What if All Tests are Negative but Symptoms Persist?

If all diagnostic tests come back negative but you continue to experience symptoms of ESRD, it is important to follow up with your healthcare provider. They may recommend repeating certain tests or performing additional evaluations to rule out other conditions that could be causing your symptoms. In some cases, early-stage kidney disease may not show up on standard tests, so close monitoring and regular follow-up appointments are essential. Your healthcare provider will work with you to determine the best course of action based on your symptoms and test results.

Treatment Options for End-Stage Renal Disease (ESRD)

Medications for Managing End-Stage Renal Disease

Erythropoietin

Erythropoietin is a hormone that stimulates the production of red blood cells. In patients with end-stage renal disease (ESRD), the kidneys often fail to produce enough erythropoietin, leading to anemia.

This medication is typically administered via injection and is used when anemia becomes severe, often when hemoglobin levels fall below a certain threshold. It is a standard treatment for anemia in ESRD patients.

Patients can expect improved energy levels and a reduction in anemia-related symptoms, such as fatigue, within a few weeks of starting treatment.

Calcium Acetate

Calcium acetate is a phosphate binder used to lower high phosphate levels in the blood, a common issue in ESRD. Elevated phosphate can lead to complications such as bone and heart problems.

This medication is taken with meals to bind phosphate in the digestive tract, preventing its absorption into the bloodstream. It is often prescribed when dietary phosphate restriction alone is insufficient.

Patients can expect a gradual reduction in phosphate levels, which helps protect bones and reduce cardiovascular risks.

Sevelamer

Sevelamer is another phosphate binder that helps control high phosphate levels in the blood. Unlike calcium-based binders, it does not increase calcium levels, making it ideal for patients who need to avoid excess calcium.

Sevelamer is taken with meals and is often used when calcium-based binders are unsuitable or when calcium levels are already elevated. It is a common second-line treatment for managing phosphate levels in ESRD.

Patients can expect improved phosphate control, which helps prevent complications such as bone disease and vascular calcification.

Lanthanum Carbonate

Lanthanum carbonate is a non-calcium phosphate binder used to lower phosphate levels in ESRD patients. It works by binding phosphate in the digestive tract, preventing its absorption.

This medication is taken with meals and is often used when other phosphate binders are ineffective or cause side effects. It is particularly useful for patients who need to avoid calcium-based treatments.

Patients can expect better phosphate control, which helps protect against bone and cardiovascular complications.

Vitamin D Analogs

Vitamin D analogs, such as calcitriol, are used to manage low calcium levels and secondary hyperparathyroidism in ESRD. These medications help regulate calcium and phosphate metabolism, which is often disrupted in kidney disease.

They are typically prescribed when blood tests show low calcium or elevated parathyroid hormone (PTH) levels. They are often used in combination with phosphate binders.

Patients can expect improved calcium balance and reduced PTH levels, helping protect bones and reduce the risk of fractures.

Iron Supplements

Iron supplements are used to treat iron deficiency, which is common in ESRD patients, especially those receiving erythropoietin therapy. Iron is essential for producing healthy red blood cells.

These supplements can be taken orally or administered intravenously, depending on the severity of the deficiency. They are often used alongside erythropoietin to improve anemia management.

Patients can expect improved iron levels, supporting red blood cell production and alleviating anemia symptoms.

Antihypertensives

Antihypertensives are used to control high blood pressure, which is common in ESRD and can worsen kidney damage. Several classes of antihypertensives are available, including ACE inhibitors, ARBs, and calcium channel blockers.

These medications are prescribed based on the patient’s blood pressure and overall health. They are often a first-line treatment for managing hypertension in ESRD patients.

Patients can expect better blood pressure control, helping slow the progression of kidney disease and reduce cardiovascular risks.

Phosphate Binders

Phosphate binders, such as calcium acetate, sevelamer, and lanthanum carbonate, are used to reduce high phosphate levels in the blood. Elevated phosphate can lead to bone and heart problems in ESRD patients.

These medications are taken with meals to bind phosphate in the digestive tract, preventing its absorption. They are often prescribed when dietary changes alone are insufficient to control phosphate levels.

Patients can expect improved phosphate control, helping protect bones and reduce cardiovascular risks.

Diuretics

Diuretics help the body eliminate excess fluid by increasing urine production. In ESRD, fluid retention can lead to swelling, high blood pressure, and heart problems.

These medications are typically used in the earlier stages of kidney disease or in patients with some remaining kidney function. They are less effective in advanced ESRD when kidney function is severely impaired.

Patients can expect reduced fluid retention, helping relieve swelling and improve blood pressure control.

Sodium Bicarbonate

Sodium bicarbonate is used to treat metabolic acidosis, a condition where the blood becomes too acidic due to the kidneys’ inability to maintain proper acid-base balance.

This medication is taken orally and is often prescribed when blood tests show low bicarbonate levels. It is commonly used in ESRD patients to help maintain a normal pH balance in the blood.

Patients can expect improved acid-base balance, helping protect muscles and bones from the harmful effects of acidosis.

Procedures for Treating End-Stage Renal Disease

Hemodialysis

Hemodialysis filters waste, excess fluid, and toxins from the blood using a dialysis machine. It is a life-saving treatment for ESRD patients whose kidneys can no longer perform these functions.

This procedure is typically performed three times a week at a dialysis center, although some patients may do it at home. It is the most common form of dialysis treatment for ESRD patients.

Patients can expect improved waste and fluid removal, relieving symptoms like fatigue, swelling, and shortness of breath. However, dialysis does not cure ESRD, and patients will need ongoing treatment.

Peritoneal Dialysis

Peritoneal dialysis uses the lining of the abdomen (the peritoneum) to filter waste and excess fluid from the blood. A special solution is introduced into the abdomen, where it absorbs waste before being drained.

This procedure can be done at home and offers more flexibility than hemodialysis. It is often recommended for patients who prefer to manage their treatment independently or who cannot tolerate hemodialysis.

Patients can expect similar benefits to hemodialysis, including improved waste and fluid removal. However, peritoneal dialysis requires daily treatment and careful management to avoid infections.

Kidney Transplant

A kidney transplant is a surgical procedure in which a healthy kidney from a donor is placed into a patient with ESRD. This is considered the most effective long-term treatment for ESRD.

Transplantation is typically recommended for patients healthy enough for surgery and with a suitable donor. It is often considered when dialysis is no longer sufficient or as an alternative to long-term dialysis.

Patients can expect a significant improvement in quality of life, as a successful transplant can restore normal kidney function. However, lifelong immunosuppressive medications are required to prevent rejection of the new kidney.

Improving End-Stage Renal Disease with Lifestyle Changes

While medical treatments are essential for managing ESRD, several lifestyle changes can help improve your condition and overall well-being:

1. Low-protein diet: Reducing protein intake can help decrease the buildup of waste products in the blood.
2. Hydration management: Drinking the right amount of fluids can help prevent dehydration and fluid overload.
3. Regular exercise: Staying active can improve your energy levels and overall health.
4. Weight management: Maintaining a healthy weight can reduce strain on your kidneys and improve blood pressure control.
5. Avoiding processed foods: Processed foods are often high in sodium and phosphorus, which can worsen kidney function.
6. Reducing sodium intake: Limiting salt can help control blood pressure and reduce fluid retention.
7. Stress management: Reducing stress through relaxation techniques can improve your overall well-being.
8. Monitoring blood pressure: Keeping your blood pressure under control is crucial for slowing the progression of kidney disease.
9. Quitting smoking: Smoking can worsen kidney damage and increase the risk of cardiovascular complications.
10. Limiting alcohol consumption: Reducing alcohol intake can help protect your kidneys and improve overall health.

It’s important to seek medical help if you experience worsening symptoms, such as increased swelling, shortness of breath, or changes in urine output. Telemedicine offers a convenient way to consult with your healthcare provider from the comfort of your home, allowing for regular monitoring and timely adjustments to your treatment plan.

Living with End-Stage Renal Disease: Tips for Better Quality of Life

Living with ESRD can be challenging, but there are steps you can take to improve your quality of life:

1. Follow your treatment plan closely, including medications, dialysis, and dietary recommendations.
2. Stay active and engage in regular physical activity to boost your energy and mood.
3. Maintain a strong support system by staying connected with family, friends, and support groups.
4. Manage stress through relaxation techniques, such as meditation, deep breathing, or yoga.
5. Stay informed about your condition and treatment options by asking questions and staying in touch with your healthcare provider.

Conclusion

End-stage renal disease is a serious condition that requires ongoing management through medications, dialysis, or kidney transplantation. Early diagnosis and treatment are crucial for slowing the progression of the disease and improving quality of life. By working closely with your healthcare provider and making lifestyle changes, you can manage your condition more effectively.

If you or a loved one is living with ESRD, our telemedicine practice is here to help. We offer convenient, compassionate care from the comfort of your home. Contact us today to schedule a consultation and take the next step in managing your health.

James Kingsley

Learn More